Tsutomu Narikiyo
Directeur/Bestuurslid bij UNIGEN Inc.
Profiel
Tsutomu Narikiyo is currently a Director at UNIGEN Inc. He previously worked as an Outside Director at UMN Pharma, Inc. and as a Deputy Manager-New Business Promotions at IHI Corp.
Narikiyo received his undergraduate degree from Seikei University in 1982.
Actieve functies van Tsutomu Narikiyo
| Bedrijven | Functie | Begin |
|---|---|---|
UNIGEN Inc.
 UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Directeur/Bestuurslid | 01-06-2010 |
Eerdere bekende functies van Tsutomu Narikiyo
| Bedrijven | Functie | Einde |
|---|---|---|
| IHI CORPORATION | Corporate Officer/Principal | - |
| UMN PHARMA INC. | Directeur/Bestuurslid | - |
Opleiding van Tsutomu Narikiyo
| Seikei University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IHI CORPORATION | Producer Manufacturing |
| Bedrijven in privébezit | 2 |
|---|---|
UMN Pharma, Inc.
 UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. | Health Technology |
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Health Technology |